AI-generated summary
The authors conducted a retrospective chart review of 52 eyes in patients with dry eye syndrome and meibomian gland dysfunction who did not respond to conventional treatment and received 2 to 5 sessions of a combined intense pulsed light and low-level light device. They report improved tear film breakup time, better meibomian gland scores and improved symptom questionnaire results, with no adverse events noted. The design was retrospective and lacked a control group.
- Participants
- 52
- Who or what was studied
- Patients with dry eye syndrome caused by meibomian gland dysfunction who were refractory to conventional medical treatment, treated at Laser Vision, Lebanon
- Limits stated in the abstract
- The study was a retrospective chart review without a control group, so the reported improvements cannot be attributed to the device with certainty.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Dry eye, Low-level laser therapy, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.